Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Dendritic cells in cancer immunotherapy

Dendritic cells in cancer immunotherapy Camille M. Le Gall, Jorieke Weiden, Loek J. Eggermont and Carl G. Figdor provide an overview of immunotherapeutics for cancer treatment that harness dendritic cells, their challenges in clinical use, and approaches employed to enhance their recruitment and activation to promote effective anti-tumour immunity. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Materials Springer Journals

Dendritic cells in cancer immunotherapy

Loading next page...
 
/lp/springer-journals/dendritic-cells-in-cancer-immunotherapy-SUZasfhk00

References (11)

Publisher
Springer Journals
Copyright
Copyright © 2018 by The Publisher
Subject
Materials Science; Materials Science, general; Optical and Electronic Materials; Biomaterials; Nanotechnology; Condensed Matter Physics
ISSN
1476-1122
eISSN
1476-4660
DOI
10.1038/s41563-018-0093-6
Publisher site
See Article on Publisher Site

Abstract

Camille M. Le Gall, Jorieke Weiden, Loek J. Eggermont and Carl G. Figdor provide an overview of immunotherapeutics for cancer treatment that harness dendritic cells, their challenges in clinical use, and approaches employed to enhance their recruitment and activation to promote effective anti-tumour immunity.

Journal

Nature MaterialsSpringer Journals

Published: May 23, 2018

There are no references for this article.